Healthcare & Life Sciences
Melodia Therapeutics
Switzerlandwww.melodiatx.com/
Melodia Therapeutics is a Healthcare & Life Sciences startup based in Switzerland.
About Melodia Therapeutics
Based in Switzerland, Melodia Therapeutics is a startup. Brouky classifies it under Healthcare & Life Sciences.
Developing a next-generation dipeptidyl peptidase 1 (DPP1) inhibitor to treat severe neutrophil-driven inflammatory diseases, with programs focused on respiratory, dermatologic, and systemic inflammatory disorders; the candidate uses a selective non‑covalent nitrile-based mechanism to inhibit DPP1.
Explore Melodia Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.